130 related articles for article (PubMed ID: 22468374)
1. [Authorities in USA don't recommend screening for prostate cancer].
Bratt O
Lakartidningen; 2011 Nov 16-22; 108(46):2362. PubMed ID: 22468374
[No Abstract] [Full Text] [Related]
2. States renewing attention to prostate cancer.
Rossiter C
NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
[No Abstract] [Full Text] [Related]
3. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
[No Abstract] [Full Text] [Related]
4. Best screening tests for prostate cancer.
Moul JW
West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
[No Abstract] [Full Text] [Related]
5. Why prostate cancer screening is necessary.
Witte MN; Lindaman BD; Rosinsky DE
S D Med; 2015; Spec No():88-91. PubMed ID: 25985616
[No Abstract] [Full Text] [Related]
6. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
7. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
Schröder FH
N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
[No Abstract] [Full Text] [Related]
8. Re: Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Hamilton RJ; Platz EA; Freedland SJ
J Natl Cancer Inst; 2009 Apr; 101(8):611-2. PubMed ID: 19351913
[No Abstract] [Full Text] [Related]
9. Prostate-specific antigen: a misused and maligned prostate cancer biomarker.
Thompson IM; Tangen CM; Kristal AR
J Natl Cancer Inst; 2008 Nov; 100(21):1487-8. PubMed ID: 18957671
[No Abstract] [Full Text] [Related]
10. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
Brett AS; Ablin RJ
N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
[No Abstract] [Full Text] [Related]
11. Prostate cancer screening: what we know, don't know, and believe.
Brawley OW
Ann Intern Med; 2012 Jul; 157(2):135-6. PubMed ID: 22801675
[No Abstract] [Full Text] [Related]
12. Screening by the prostate-specific antigen test: what do the patients know?
Diefenbach PN; Ganz PA; Pawlow AJ; Guthrie D
J Cancer Educ; 1996; 11(1):39-44. PubMed ID: 8777154
[TBL] [Abstract][Full Text] [Related]
13. PSA screening: the bottom line.
Elhilali MM
CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
[No Abstract] [Full Text] [Related]
14. Is screening for prostate cancer the current gold standard?--"no".
Kramer BS; Gohagan JK; Prorok PC
Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515
[No Abstract] [Full Text] [Related]
15. Is screening for prostate cancer the current gold standard?--"yes".
Lange PH
Eur J Cancer; 1997 Mar; 33(3):354-6. PubMed ID: 9155516
[No Abstract] [Full Text] [Related]
16. PSA screening: a view from the front lines. North York General-Branson Practice-Based Small Group.
Greiver M; Rosen N
CMAJ; 2000 Mar; 162(6):789-90. PubMed ID: 10750465
[No Abstract] [Full Text] [Related]
17. New PSA guidelines discourage overscreening.
Peres J
J Natl Cancer Inst; 2012 Jan; 104(1):8-9. PubMed ID: 22173585
[No Abstract] [Full Text] [Related]
18. [The prostate specific antigen: what can we learn from the American experience?].
Zhao XJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
[No Abstract] [Full Text] [Related]
19. [Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary].
Damber JE
Lakartidningen; 2003 Sep; 100(38):2916-8, 2921. PubMed ID: 14558209
[No Abstract] [Full Text] [Related]
20. Screening for prostate cancer - will we ever know?
Adolfsson J
Acta Oncol; 2010 Apr; 49(3):275-7. PubMed ID: 20397764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
